BTTX (Better Therapeutics) OCF Margin %: 0.00% (As of Sep. 2023)


What is Better Therapeutics OCF Margin %?

Better Therapeutics BTTX OCF Margin % is 0.00% as of Sep. 2023.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Better Therapeutics's Cash Flow from Operations for the three months ended in Sep. 2023 was $-5.94 Mil. Better Therapeutics's Revenue for the three months ended in Sep. 2023 was $0.00 Mil. Therefore, Better Therapeutics's OCF Margin % for the quarter that ended in Sep. 2023 was 0.00%.

As of today, Better Therapeutics's current OCF Yield % is -212,000.00%.

The historical rank and industry rank for Better Therapeutics's OCF Margin % or its related term are showing as below:


BTTX's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

Better Therapeutics OCF Margin % Related Terms

Better Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Better Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Better Therapeutics OCF Margin % Chart

Better Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22
OCF Margin %
-34,538.89 -72,175.00 0.00 0.00

Better Therapeutics Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Better Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Better Therapeutics's OCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-28.93/0
= %

Better Therapeutics's OCF Margin for the quarter that ended in Sep. 2023 is calculated as

OCF Margin=Cash Flow from Operations (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-5.943/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Better Therapeutics (BTTX) has a OCF Margin % of 0.00% as of Sep. 2023. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Better Therapeutics and its competitors.
Is Better Therapeutics' OCF Margin % too high?
Better Therapeutics' current OCF Margin % is 0.00%.
How does Better Therapeutics' OCF Margin % compare to CYCN and CELZ?
Better Therapeutics' OCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Better Therapeutics and its competitors. Better Therapeutics's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Better Therapeutics stock overvalued right now?
Better Therapeutics (BTTX) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Better Therapeutics (BTTX), the current OCF Margin % is 0.00% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Better Therapeutics Business Description

Address 548 Market Street, Suite 49404, San Francisco, CA, USA, 94104
Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions.